PCSK9

Novartis’ $9.7B PCSK9 drug nabs first OK — now comes the challenge of finding a market
Endpoints
Fri, 12/11/20 - 11:06 am
Europe
Novartis
PCSK9
inclisiran
Regeneron, Sanofi Strongly Disagree to Jury’s Verdict in Amgen Patent Trial
Bidness, ETC
Wed, 03/16/16 - 07:22 pm
Sanofi
Regeneron
Amgen
patents
PCSK9
Repatha
Praluent
Regeneron, Sanofi Take Step Forward With Cholesterol Drug
Minyanville
Mon, 11/5/12 - 11:05 am
Regeneron
Sanofi
PCSK9
LDL cholesterol
Amgen
AMG145
SAR236553/REGN727
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Regeneron
Sanofi
hypercholesterolemia
PCSK9
Amgen
Merck
Alnylam
Bristol-Myers Squibb
REGN727